Similarly, miR-542-5p was identified as a potential biomarker in von Hippel–Lindau (VHL)-associated ccRCC, with expression levels increasing in tumor-bearing patients and returning to baseline after nephrectomy [26,42]. The gene discussed is VHL; the disease is neoplasm.